Search Results - "Hook, Jane M"

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial by Bielack, Stefan S, Smeland, Sigbjørn, Whelan, Jeremy S, Marina, Neyssa, Jovic, Gordana, Hook, Jane M, Krailo, Mark D, Gebhardt, Mark, Pápai, Zsuzsanna, Meyer, James, Nadel, Helen, Randall, R Lor, Deffenbaugh, Claudia, Nagarajan, Rajaram, Brennan, Bernadette, Letson, G Douglas, Teot, Lisa A, Goorin, Allen, Baumhoer, Daniel, Kager, Leo, Werner, Mathias, Lau, Ching C, Sundby Hall, Kirsten, Gelderblom, Hans, Meyers, Paul, Gorlick, Richard, Windhager, Reinhard, Helmke, Knut, Eriksson, Mikael, Hoogerbrugge, Peter M, Schomberg, Paula, Tunn, Per-Ulf, Kühne, Thomas, Jürgens, Heribert, van den Berg, Henk, Böhling, Tom, Picton, Susan, Renard, Marleen, Reichardt, Peter, Gerss, Joachim, Butterfass-Bahloul, Trude, Morris, Carol, Hogendoorn, Pancras C W, Seddon, Beatrice, Calaminus, Gabriele, Michelagnoli, Maria, Dhooge, Catharina, Sydes, Matthew R, Bernstein, Mark

“…EURAMOS-1, an international randomized controlled trial, investigated maintenance therapy with pegylated interferon alfa-2b (IFN-α-2b) in patients whose…”
Get full text

Maintenance therapy in ovarian cancer by Khalique, Saira, Hook, Jane M, Ledermann, Jonathan A

“…PURPOSE OF REVIEWTargeted therapies are being used as maintenance therapy to improve the outcome of ovarian cancer following standard treatment in the…”
Get full text

The European Society for Medical Oncology 2014 Congress: Highlights and summary of selected abstracts in gynecologic cancers by Hook, Jane M, Ledermann, Jonathan A

Get full text

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup by McTiernan, Anne, Jinks, Rachel C, Sydes, Matthew R, Uscinska, Barbara, Hook, Jane M, van Glabbeke, Martine, Bramwell, Vivien, Lewis, Ian J, Taminiau, Antonie H.M, Nooij, Marianne A, Hogendoorn, Pancras C.W, Gelderblom, Hans, Whelan, Jeremy S

“…Abstract Aim Chemotherapy-induced toxicity is an independent prognostic indicator in several cancers. We aimed to determine whether toxicity was related to…”
Get full text

Biomarkers in the development of anti-angiogenic therapies for ovarian cancer by Raja, Fharat A, Hook, Jane M, Ledermann, Jonathan A

“…Abstract The treatment of ovarian cancer remains challenging as the majority of patients will relapse and die from their disease despite successful first-line…”
Get full text

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial by Marina, Neyssa M, Prof, Smeland, Sigbjørn, Prof, Bielack, Stefan S, Prof, Bernstein, Mark, Prof, Jovic, Gordana, PhD, Krailo, Mark D, PhD, Hook, Jane M, MRCP, Arndt, Carola, Prof, van den Berg, Henk, MD, Brennan, Bernadette, MD, Brichard, Bénédicte, Prof, Brown, Ken L B, MD, Butterfass-Bahloul, Trude, MD, Calaminus, Gabriele, MD, Daldrup-Link, Heike E, MD, Eriksson, Mikael, MD, Gebhardt, Mark C, MD, Gelderblom, Hans, Prof, Gerss, Joachim, PhD, Goldsby, Robert, MD, Goorin, Allen, MD, Gorlick, Richard, Prof, Grier, Holcombe E, Prof, Hale, Juliet P, MD, Hall, Kirsten Sundby, MD, Hardes, Jendrik, Prof, Hawkins, Douglas S, MD, Helmke, Knut, Prof, Hogendoorn, Pancras C W, Prof, Isakoff, Michael S, MD, Janeway, Katherine A, MD, Jürgens, Heribert, Prof, Kager, Leo, MD, Kühne, Thomas, Prof, Lau, Ching C, MD, Leavey, Patrick J, Prof, Lessnick, Stephen L, Prof, Mascarenhas, Leo, MD, Meyers, Paul A, Prof, Mottl, Hubert, MD, Nathrath, Michaela, Prof, Papai, Zsuzsanna, Prof, Randall, R Lor, Prof, Reichardt, Peter, MD, Renard, Marleen, MD, Safwat, Akmal Ahmed, PhD, Schwartz, Cindy L, Prof, Stevens, Michael C G, Prof, Strauss, Sandra J, PhD, Teot, Lisa, MD, Werner, Mathias, MD, Sydes, Matthew R, MSc, Whelan, Jeremy S, Prof

“…Summary Background We designed the EURAMOS-1 trial to investigate whether intensified postoperative chemotherapy for patients whose tumour showed a poor…”
Get full text